Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03770689
Title Phase Ib/II Study of M3814 in Combination With Capecitabine and Radiotherapy in Rectal Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

rectum cancer

Therapies

Capecitabine

Capecitabine + Peposertib

Age Groups: adult | senior
Covered Countries USA | ESP


No variant requirements are available.